ERBB2 and breast cancer: According to the facts that have been previously reported, we speculated that MALAT1 and Her-2 have common downstream signaling pathways (including PI3K-Akt [9] and RAS-MAPK [14]), and could interact with each other to regulate progression of Her-2 positive breast cancer.